Genetix Biotherapeutics and the National Football League Alumni Association Announce Partnership
08/18/2026
Our gene addition technology targets the underlying cause of disease with a single dose, using a patient's own cells
Genetix has three FDA-approved one-time treatments for rare diseases—with a focus on hematology—and one of the most robust datasets in the field
Support and guidance to help you understand and navigate your path to a potential cure
Recent News
08/18/2026
06/23/2026
03/02/2026
12/08/2025
12/06/2025
Meet Charlotte, living with sickle cell disease. Alongside her family, she is dedicated to raising awareness and supporting others impacted by the condition.
Meet Charlotte, living with sickle cell disease. Alongside her family, she is dedicated to raising awareness and supporting others impacted by the condition.
You are about to leave the Genetix Biotherapeutics website and enter a product-specific website.